Firmaet vil gennemføre en undersøgelse af virkningen af Yondelis hos patienter med kræft af typen myksoidt liposarkom.
The company that makes Yondelis will continue to assess which patients are more likely to respond to the medicine, and will carry out a study to investigate the effects of Yondelis in patients with a type of cancer called ‘ myxoid liposarcoma’.